Paper36966149
Continuous Spatiotemporal Therapy of A Full-API Nanodrug via Multi-Step Tandem Endogenous Biosynthesis.
Fang F and 6 others. Nat Commun, 2023. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Continuous Spatiotemporal Therapy of A Full-API Nanodrug via Multi-Step Tandem Endogenous Biosynthesis. Papers, record 36966149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36966149
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Continuous Spatiotemporal Therapy of A Full-API Nanodrug via Multi-Step Tandem Endogenous Biosynthesis.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Curcumin | Major topic |
| Photochemotherapy | Major topic |
| Neoplasms | Major topic |
| Nanoparticles | Major topic |
| Humans | |
| Photosensitizing Agents | |
| Aminolevulinic Acid | |
| Protoporphyrins |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31033145 | A Biomimetic Coordination Nanoplatform for Controlled Encapsulation and Delivery of Drug-Gene Combinations. | Angew Chem Int Ed Engl | 2019 | https://conductscience.org/library/papers/31033145 | PubMed |
| 2 | 33543529 | NIR-Actuated Remote Activation of Ferroptosis in Target Tumor Cells through a Photothermally Responsive Iron-Chelated Biopolymer Nanoplatform. | Angew Chem Int Ed Engl | 2021 | https://conductscience.org/library/papers/33543529 | PubMed |
| 3 | 33045313 | Carrier-free nanodrugs for safe and effective cancer treatment. | J Control Release | 2021 | https://conductscience.org/library/papers/33045313 | PubMed |
| 4 | 26390118 | Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo. | ACS Nano | 2015 | https://conductscience.org/library/papers/26390118 | PubMed |
| 5 | 34528355 | Smart Tumor-Cell-Derived Microparticles Provide On-Demand Photosensitizer Synthesis and Hypoxia Relief for Photodynamic Therapy. | Angew Chem Int Ed Engl | 2021 | https://conductscience.org/library/papers/34528355 | PubMed |
| 6 | 32374941 | MOF-Derived Double-Layer Hollow Nanoparticles with Oxygen Generation Ability for Multimodal Imaging-Guided Sonodynamic Therapy. | Angew Chem Int Ed Engl | 2020 | https://conductscience.org/library/papers/32374941 | PubMed |
| 7 | 27485478 | Multistimuli-Responsive Bilirubin Nanoparticles for Anticancer Therapy. | Angew Chem Int Ed Engl | 2016 | https://conductscience.org/library/papers/27485478 | PubMed |
| 8 | 35918816 | Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier-Free Nanoassembly of Fluorinated Prodrug and siRNA. | Adv Mater | 2022 | https://conductscience.org/library/papers/35918816 | PubMed |
| 9 | 29257865 | Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care. | ACS Nano | 2018 | https://conductscience.org/library/papers/29257865 | PubMed |
| 10 | 32020029 | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. | Cell Res | 2020 | https://conductscience.org/library/papers/32020029 | PubMed |
| 11 | 34705318 | Thermally Activated Delayed Fluorescence Material: An Emerging Class of Metal-Free Luminophores for Biomedical Applications. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34705318 | PubMed |
| 12 | 17822372 | Heme oxygenase-1 in tumors: is it a false friend? | Antioxid Redox Signal | 2007 | https://conductscience.org/library/papers/17822372 | PubMed |
| 13 | 37325605 | Indocyanine green potentiated paclitaxel nanoprodrugs for imaging and chemotherapy. | Exploration (Beijing) | 2022 | https://conductscience.org/library/papers/37325605 | PubMed |
| 14 | 31854064 | Molecularly Engineered Macrophage-Derived Exosomes with Inflammation Tropism and Intrinsic Heme Biosynthesis for Atherosclerosis Treatment. | Angew Chem Int Ed Engl | 2020 | https://conductscience.org/library/papers/31854064 | PubMed |
| 15 | 31374171 | Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy. | ACS Nano | 2019 | https://conductscience.org/library/papers/31374171 | PubMed |
| 16 | 35199998 | Carrier-Free Trehalose-Based Nanomotors Targeting Macrophages in Inflammatory Plaque for Treatment of Atherosclerosis. | ACS Nano | 2022 | https://conductscience.org/library/papers/35199998 | PubMed |
| 17 | 27834398 | Cancer nanomedicine: progress, challenges and opportunities. | Nat Rev Cancer | 2017 | https://conductscience.org/library/papers/27834398 | PubMed |
| 18 | 34145984 | Metal-Coordinated Supramolecular Self-Assemblies for Cancer Theranostics. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34145984 | PubMed |
| 19 | 31034982 | Carbon monoxide (CO)-Strengthened cooperative bioreductive anti-tumor therapy via mitochondrial exhaustion and hypoxia induction. | Biomaterials | 2019 | https://conductscience.org/library/papers/31034982 | PubMed |
| 20 | 35018711 | Near-Infrared Thermally Activated Delayed Fluorescence Nanoparticle: A Metal-Free Photosensitizer for Two-Photon-Activated Photodynamic Therapy at the Cell and Small Animal Levels. | Small | 2022 | https://conductscience.org/library/papers/35018711 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931284 | Dual-Responsive Nanoparticles for Prodrug Activation and Copper-Dependent Cell Death. | Nanomaterials (Basel) | 2026 | https://conductscience.org/library/papers/42931284 | PubMed |
| 42707772 | Programmable Self-Assembly of Traditional Chinese Medicine (TCM) Monomers: From Molecular Mechanisms to Multifunctional Nanomedicine. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42707772 | PubMed |
| 42694573 | Beyond Glucose and Lipids: The Pivotal Role of Amino Acid Reprogramming in Shaping the Tumor Microenvironment and Guiding the Development of Novel Therapeutics. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/42694573 | PubMed |
| 42630814 | Trojan horse-inspired vaccine-like nanoparticle with enhanced lubrication and active-passive synergistic anti-inflammation for post-traumatic osteoarthritis treatment. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42630814 | PubMed |
| 42541146 | Quadruplex Bioactive FAND for Treating Acute Liver Failure Induced by Acetaminophen or Hepatectomy. | Exploration (Beijing) | 2026 | https://conductscience.org/library/papers/42541146 | PubMed |
| 42453590 | Advances in porphyrin-based photosensitizers for photodynamic therapy of A549 lung cancer. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42453590 | PubMed |
| 42178779 | Redesign of the Ferritin Ferroxidase Center for Universal Molecular Binding or Specific Recognition. | Small | 2026 | https://conductscience.org/library/papers/42178779 | PubMed |
| 42023294 | Synthesis and antibacterial properties of magnesium-based curcumin self-assembled material. | Curr Res Food Sci | 2026 | https://conductscience.org/library/papers/42023294 | PubMed |
| 41692829 | Biomimetic metal-drug coordination nanoplatform to counteract drug resistance in Pseudomonas aeruginosa via energy disruption. | Nat Commun | 2026 | https://conductscience.org/library/papers/41692829 | PubMed |
| 41683531 | A UHPLC-Orbitrap-MS Metabolomics Strategy Reveals Glycerophospholipid Metabolic Remodeling Is Associated with the Anti-Arthritic Effect of Glycyrrhiza Protein-Paeoniflorin Nanoparticles via PI3K/AKT/NLRP3 Axis. | Molecules | 2026 | https://conductscience.org/library/papers/41683531 | PubMed |
| 41618406 | Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41618406 | PubMed |
| 41560796 | Metformin glycyrrhetinic acid binary injectable hydrogel for synergistic tumor immunotherapy via spatiotemporal microenvironment remodeling. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41560796 | PubMed |
| 41531499 | Cascade-driven nanomotor with self-amplifying necrosis targeting and deep tumor penetration for enhanced type I photodynamic immunotherapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41531499 | PubMed |
| 41530858 | Supramolecular self-assembly in Traditional Chinese Medicine: molecular mechanisms, material basis of decoction efficacy, compatibility interpretation, and biomedical applications. | Chin Med | 2026 | https://conductscience.org/library/papers/41530858 | PubMed |
| 41524227 | Antibody-Empowered Nanomedicine for Precise Biomedical Applications. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41524227 | PubMed |
| 41421661 | Assembly delivery of bioactive matters: Advances, challenges, and prospects. | J Adv Res | 2026 | https://conductscience.org/library/papers/41421661 | PubMed |
| 41169794 | Mechanical energy-charged navigating pump repair natural vascular scaffolds to reverse osteoporosis. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41169794 | PubMed |
| 40968167 | 5-ALA photodynamic metabolite-powered zero-waste ferroptosis amplifier for enhanced hypertrophic scar therapy. | Nat Commun | 2025 | https://conductscience.org/library/papers/40968167 | PubMed |
| 40948584 | Dual metabolism-disrupted nanoparticles for reprogramming the immune microenvironment to potentiate cuproptosis immunotherapy. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40948584 | PubMed |
| 40824119 | Controlling nanocage assembly, towards developing a one-health "plug & play" platform for targeted therapy. | Chem Commun (Camb) | 2025 | https://conductscience.org/library/papers/40824119 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HMOX1 | 3162 | PubTator's text mining | https://conductscience.org/library/genes/3162 | NCBI Gene |
| UQCC6 | 728568 | PubTator's text mining | https://conductscience.org/library/genes/728568 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36966149
GET https://conductscience.org/api/papers/v1/36966149/references?page=2